Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Kotecha, Abhay ^c   Perez Martin, Eva ^a   Harvey, Yongjie ^a   Zhang, Fuquan ^a   Ilca, Serban L ^c   Fry, Elizabeth E ^c   Jackson, Ben ^a   Maree, Francois ^b   Scott, Katherine ^b   Hecksel, Corey W ^e   Harmsen, Michiel M ^d   Mioulet, Valérie ^a   Wood, Britta ^a   Juleff, Nick ^a   Stuart, David I ^c,e   Charleston, Bryan ^a   Seago, Julian ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e DIAMOND LIGHT SOURCE LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; CELL LINE; CHIMERA; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETICS; GOAT; HAMSTER; IMMUNOLOGY; PIG; VIRUS CAPSID;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; CELL LINE; CHIMERA; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GOATS; SWINE; VIRAL VACCINES;

EID: 85053213670     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-31856-x     Document Type: Article

References (47)

1. Grubman, M. J. & Baxt, B. Foot-and-mouth disease. Clin Microbiol Rev 17, 465–93 (2004).
2. Forss, S., Strebel, K., Beck, E. & Schaller, H. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res 12, 6587–601 (1984).
3. Fry, E. E., Stuart, D. I. & Rowlands, D. J. The structure of foot-and-mouth disease virus. Curr Top Microbiol Immunol 288, 71–101 (2005).
4. Acharya, R. et al. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337, 709–16 (1989).
5. Smyth, M. S. & Martin, J. H. Picornavirus uncoating. Mol Pathol 55, 214–9 (2002).
6. Paton, D. J. et al. Selection of foot and mouth disease vaccine strains–a review. Rev Sci Tech 24, 981–93 (2005).
7. Bastos, A. D. et al. The implications of virus diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa. J Gen Virol 84, 1595–606 (2003).
8. Doel, T. R. & Baccarini, P. J. Thermal stability of foot-and-mouth disease virus. Arch Virol 70, 21–32 (1981).
9. Botner, A. et al. Capsid proteins from field strains of foot-and-mouth disease virus confer a pathogenic phenotype in cattle on an attenuated, cell-culture-adapted virus. J Gen Virol 92, 1141–51 (2011).
10. Seago, J. et al. Characterization of epitope-tagged foot-and-mouth disease virus. J Gen Virol 93, 2371–81 (2012).
11. Berryman, S. et al. Positively charged residues at the five-fold symmetry axis of cell culture-adapted foot-and-mouth disease virus permit novel receptor interactions. J Virol 87, 8735–44 (2013).
12. Seago, J. et al. An infectious recombinant foot-and-mouth disease virus expressing a fluorescent marker protein. J Gen Virol 94, 1517–27 (2013).
13. van Rensburg, H. G., Henry, T. M. & Mason, P. W. Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J Gen Virol 85, 61–8 (2004).
14. Brown, F. & Cartwright, B. Purification of Radioactive Foot-and-Mouth Disease Virus. Nature 199, 1168–70 (1963).
15. Walter, T. S. et al. A plate-based high-throughput assay for virus stability and vaccine formulation. J Virol Methods 185, 166–70 (2012).
16. Kotecha, A. et al. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation. J Gen Virol 97, 1557–65 (2016).
17. Kotecha, A. et al. Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design. Nat Struct Mol Biol 22, 788–94 (2015).
18. Harmsen, M. M. et al. Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control. Front Immunol 8, 960 (2017).
19. Logan, D. et al. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362, 566–8 (1993).
20. Barnett, P. V., Statham, R. J., Vosloo, W. & Haydon, D. T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 21, 3240–8 (2003).
21. Van Rensburg, H. G. & Mason, P. W. Construction and evaluation of a recombinant foot-and-mouth disease virus: implications for inactivated vaccine production. Ann N Y Acad Sci 969, 83–7 (2002).
22. Brown, F. & Cartwright, B. Dissociation of foot-and-mouth disease virus into its nucleic acid and protein components. Nature 192, 1163–4 (1961).
23. Harmsen, M. M., Fijten, H. P., Westra, D. F. & Coco-Martin, J. M. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles. Vaccine 29, 2682–90 (2011).
24. Harmsen, M. M. et al. Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease. Vet Microbiol 120, 193–206 (2007).
25. Ma, L. N. et al. An overview on ELISA techniques for FMD. Virol J 8, 419 (2011).
26. Curry, S. et al. Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J Virol 69, 430–8 (1995).
27. Panjwani, A. et al. Capsid protein VP4 of human rhinovirus induces membrane permeability by the formation of a size-selective multimeric pore. PLoS Pathog 10, e1004294 (2014).
28. Shukla, A., Padhi, A. K., Gomes, J. & Banerjee, M. The VP4 Peptide of Hepatitis A Virus Ruptures Membranes through Formation of Discrete Pores. J Virol 88, 12409–21 (2014).
29. Ren, J. et al. Picornavirus uncoating intermediate captured in atomic detail. Nat Commun 4, 1929 (2013).
30. Curry, S. et al. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71, 9743–52 (1997).
31. Scott, K. A. et al. SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability. J Virol 91 (2017).
32. Rincon, V. et al. Identification of the structural basis of thermal lability of a virus provides a rationale for improved vaccines. Structure 22, 1560–70 (2014).
33. Maree, F. F. et al. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge. Vaccine 33, 2909–16 (2015).
34. Blignaut, B., Visser, N., Theron, J., Rieder, E. & Maree, F. F. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs. J Gen Virol 92, 849–59 (2011).
35. Maree, F. F., Blignaut, B., de Beer, T. A., Visser, N. & Rieder, E. A. Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses. Virus Res 153, 82–91 (2010).
36. Chamberlain, K. et al. Identification of a novel cell culture adaptation site on the capsid of foot-and-mouth disease virus. J Gen Virol 96, 2684–92 (2015).
37. Brehm, K. E., Ferris, N. P., Lenk, M., Riebe, R. & Haas, B. Highly sensitive fetal goat tongue cell line for detection and isolation of foot-and-mouth disease virus. J Clin Microbiol 47, 3156–60 (2009).
38. Sandberg, K., Mastronarde, D. N. & Beylkin, G. A fast reconstruction algorithm for electron microscope tomography. J Struct Biol 144, 61–72 (2003).
39. Li, X. et al. Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. Nat Methods 10, 584–90 (2013).
40. Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180, 519–30 (2012).
41. Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J Comput Chem 25, 1605–12 (2004).
42. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126–32 (2004).
43. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213–21 (2010).
44. Bolwell, C., Parry, N. R. & Rowlands, D. J. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22. J Gen Virol 73(Pt 3), 727–31 (1992).
45. OIE. Foot-and-Mouth Disease, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds, and Bees. (Paris, 2012).
46. Golding, S. M., Hedger, R. S. & Talbot, P. Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. Res Vet Sci 20, 142–7 (1976).
47. Kärber, G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Archiv f experiment Pathol u Pharmakol 162, 480–483 (1931).